AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver fibrosis and…

Continue Reading

News Source: medicalxpress.com